This inventor holds 1 USPTO granted patent. Top assignees: Johns Hopkins University, Temple University. Active years: 2018.
Company Filing History:
1 out of 3,795 
1 out of 423 
Years Active: 2018
Title: The Innovations of Carlos A. Barrerro
Introduction
Carlos A. Barrerro is an accomplished inventor based in Philadelphia, PA. He is known for his significant contributions to the field of neurocognitive disorders associated with HIV-1. His innovative approach has led to advancements in the detection and understanding of these conditions.
Latest Patents
Carlos A. Barrerro holds a patent for a method of detecting HIV-1-associated neurocognitive disorders. This patent outlines a process for identifying mild neurocognitive disturbance (MNCD) or HIV-associated dementia (HAD) in patients. The method involves detecting levels of acetyl spermine and/or acetyl spermidine in cerebrospinal fluid samples and comparing these levels to control samples. An elevated level of these compounds indicates the presence of MNCD or HAD, providing a crucial tool for diagnosis and monitoring.
Career Highlights
Throughout his career, Barrerro has worked with prestigious institutions such as Temple University and The Johns Hopkins University. His research has focused on the intersection of neurobiology and HIV, contributing to a deeper understanding of how the virus affects cognitive functions.
Collaborations
Carlos A. Barrerro has collaborated with notable colleagues in his field, including Salim Merali and Kamel Khalili. These partnerships have enhanced his research and expanded the impact of his work on HIV-related neurocognitive disorders.
Conclusion
Carlos A. Barrerro's innovative work in detecting HIV-1-associated neurocognitive disorders has made a significant impact in the medical field. His contributions continue to advance the understanding and treatment of these complex conditions.